Holen Sie sich die Stockscreener-App
284.02
0.83%
2.34
Handel nachbörslich:
281.01
-3.01
-1.06%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$281.68
Offen:
$285
24-Stunden-Volumen:
2.29M
Relative Volume:
0.70
Marktkapitalisierung:
$152.82B
Einnahmen:
$32.53B
Nettoeinkommen (Verlust:
$4.23B
KGV:
36.37
EPS:
7.81
Netto-Cashflow:
$6.28B
1W Leistung:
+2.21%
1M Leistung:
+9.53%
6M Leistung:
-14.78%
1J Leistung:
-9.73%
1-Tages-Spanne:
$281.64
$285.69
1-Wochen-Bereich:
$273.50
$285.69
52-Wochen-Spanne:
$253.30
$346.85
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Vergleichen Sie AMGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
284.02 | 152.82B | 32.53B | 4.23B | 6.28B | 7.81 |
|
LLY
Lilly Eli Co
|
823.23 | 778.66B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
85.34 | 379.90B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
152.87 | 344.63B | 88.82B | 14.07B | 19.03B | 5.79 |
|
ABBV
Abbvie Inc
|
175.65 | 310.55B | 55.53B | 5.12B | 15.62B | 2.88 |
|
MRK
Merck Co Inc
|
98.95 | 251.88B | 63.17B | 12.15B | 14.84B | 4.77 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-10-14 | Herabstufung | Truist | Buy → Hold |
| 2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Ibex Wealth Advisors Increases Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Here's Why Amgen (AMGN) is a Strong Momentum Stock - Yahoo Finance
Amgen Inc. (NASDAQ:AMGN) Shares Sold by New England Research & Management Inc. - MarketBeat
Milestone Asset Management LLC Buys 2,685 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
AMGN: 3 Biotech Stocks Revolutionizing Healthcare - StockNews.com
Citigroup Has Lowered Expectations for Amgen (NASDAQ:AMGN) Stock Price - Defense World
Amgen's SWOT analysis: stock outlook amid obesity drug race, pipeline progress - Investing.com
Federal Court delists Regeneron patent, clearing path for Amgen biosimilar launch - Law360 Canada
Swedbank AB Buys 25,482 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Set to Report Q4 Earnings: Is a Beat in the Cards? - MSN
Forsta AP Fonden Sells 4,200 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Premenstrual Syndrome Treatment Market May See Big Move: Major - openPR
Here's Why Amgen (AMGN) is a Strong Value Stock - Yahoo Finance
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Foster Victor Wealth Advisors LLC - MarketBeat
Montrusco Bolton Investments Inc. Sells 375,906 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
BMO Capital Adjusts Price Target on Amgen to $346 From $362, Keeps Outperform Rating - Marketscreener.com
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Amgen and Celltrion settle biosimilars patent dispute - The Pharma Letter
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Twelve Points Wealth Management LLC - MarketBeat
Perigon Wealth Management LLC Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Blue Trust Inc. - MarketBeat
2,647 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by Union Bancaire Privee UBP SA - MarketBeat
Amgen (AMGN) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Celltrion Settlement Puts Prolia And Xgeva Biosimilars On Ice – But Only Until June - News & Insights
Bensler LLC Sells 3,489 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Matrix Asset Advisors Inc. NY Has $24.25 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (NASDAQ:AMGN) Price Target Cut to $295.00 by Analysts at Citigroup - MarketBeat
Analyst Expectations For Amgen's Future - Benzinga
BankPlus Wealth Management LLC Takes $475,000 Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Citigroup Adjusts Price Target on Amgen to $295 From $310, Maintains Neutral Rating - Marketscreener.com
Lebenthal Global Advisors LLC Raises Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Foundations Investment Advisors LLC Increases Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Biotech Giant Amgen Launches Media Review 07/22/2024 - MediaPost Communications
Drive Wealth Management LLC Invests $236,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (AMGN) Expected to Announce Earnings on Tuesday - MarketBeat
This Is What Whales Are Betting On Amgen - Benzinga
Amgen Deal Blocks Celltrion's Bone-Drug Biosimilars Until June - Bloomberg Law
Is Most-Watched Stock Amgen Inc. (AMGN) Worth Betting on Now? - MSN
Biological Drugs Strategic Research Report 2024-2030, Profiles of 45+ Players Including Abbott Laboratories, Amgen, Baxter, Biogen, BMS, Eli Lilly and Co, GSK, Merck, Novartis, and Pfizer - GlobeNewswire Inc.
Baldwin Wealth Partners LLC MA Sells 1,282 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Granite Group Advisors LLC Has $2.29 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stake Cut by Marshall Financial Group LLC - MarketBeat
Exchange Traded Concepts LLC Purchases 1,464 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen opens new drug substance facility in North Carolina, US - Yahoo Finance
Avior Wealth Management LLC Cuts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Blue Square Asset Management LLC Acquires 7,277 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Jamison Private Wealth Management Inc. Buys 997 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Alan B Lancz & Associates Inc. - MarketBeat
DGS Capital Management LLC Has $392,000 Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by SG Americas Securities LLC - MarketBeat
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):